The Board of Directors of Emplicure AB has decided to change the date of the company's Annual General Meeting to June 13, 2023. Further information regarding the AGM will be published in the call, which will be published no later than 4 weeks before the AGM. The 2022 Annual Report will be published no later than May 23.
For additional information, please contact
CEO Phone: +46 702 569 500 Email: email@example.com
Emplicure develops new and innovative products by combining existing and approved active substances with advanced materials science within ceramic biomaterials. The product portfolio is focused on chronic pain and on abuse-deterrent formulations. The subsidiary Amplicon AB develops consumer products with oral nicotine as the first product. The share is listed on Nasdaq First North Growth Market (EMPLI). Read more at www.emplicure.com